| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968139 | Vaccine | 2011 | 5 Pages |
Abstract
⺠The immunogenicity of monovalent hepatitis B vaccine was evaluated among older adults during an outbreak response. ⺠The overall vaccine response rate was 33%. ⺠Age was only significant predictor of seroprotection. ⺠Populations at risk of hepatitis B are more likely to benefit from vaccination at earlier ages. ⺠Use of double dose or extra-doses of hepatitis B vaccine might be alternative considerations among older adults.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Rania A. Tohme, Debo Awosika-Olumo, Carrie Nielsen, Salma Khuwaja, Jennifer Scott, Jian Xing, Jan Drobeniuc, Dale J. Hu, Cynthia Turner, Toni Wafeeg, Umid Sharapov, Philip R. Spradling,